|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:1061-1068
© 2008 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Harvard School of Public Health, Boston, Mass
b Division of Cardiovascular Surgery, Mayo Clinic and Foundation, Rochester, Minn
Received for publication August 28, 2007; revisions received October 11, 2007; accepted for publication October 19, 2007. * Address for reprints: Andrew W. ElBardissi, BS, Harvard School of Public Health 677 Huntington Ave, Boston, MA 02115 (Email: delbardissi{at}partners.org).
Objective: We sought to compare clinical and pathologic characteristics of ventricular tumors and to detect whether differences exist in short- and long-term survival after resection.
Methods: From 1964 to 2005, 323 patients had cardiac surgery for resection of primary cardiac tumors; 53 (16%) patients had primary ventricular tumors. We randomly sampled 53 characteristics of ventricular tumors.
Results: Patients with ventricular tumors were younger than those with atrial tumors (34.8 vs 54.6 years; P < .0001). New York Heart Association functional status was similar at presentation, although patients with atrial tumors had increased risk of atrial fibrillation (P < .05), thromboembolic events (P = .04), and mitral stenosis (P = .008) at the time of presentation. Patients with ventricular tumors had an increased incidence of myocardial invasion (14% vs 2%; P = .02) and had significantly longer cardiopulmonary bypass (80 vs 65 minutes; P < .05) and crossclamp (52 vs 39 minutes; P = .03) times. Operative mortality was 4% and 0% in the ventricular and atrial groups, respectively (P = not significant). Follow-up was obtained in 89% of patients at a mean follow-up time of 7.21 years. A Kaplan–Meier survival plot demonstrated no difference in survival characteristics of both groups. At follow-up, 81% and 74% of ventricular and atrial tumors, respectively, were minimally symptomatic (New York Heart Association class I/II; P = .13). Patients with atrial and ventricular tumors had a 6% and 0% tumor recurrence rate, respectively (P = .12).
Conclusion: Surgical resection for ventricular tumors is effective and results in excellent long-term outcome. Early surgical treatment should be strongly considered in patients with primary ventricular tumors.
This article has been cited by other articles:
![]() |
C. Y. Miyake, P. J. Del Nido, M. E. Alexander, F. Cecchin, C. I. Berul, J. K. Triedman, T. Geva, and E. P. Walsh Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J. Am. Coll. Cardiol., October 25, 2011; 58(18): 1903 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qin, L. Chen, R.-g. Wen, and Y.-b. Xiao Total correction of tetralogy of Fallot associated with rhabdomyoma in the right ventricle J. Thorac. Cardiovasc. Surg., February 1, 2011; 141(2): e20 - e22. [Full Text] [PDF] |
||||
![]() |
A. W. ElBardissi, J. A. Dearani, R. C. Daly, C. J. Mullany, T. A. Orszulak, F. J. Puga, and H. V. Schaff Embolic Potential of Cardiac Tumors and Outcome After Resection: A Case-Control Study Stroke, January 1, 2009; 40(1): 156 - 162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |